Abstract

Objective. To estimate the possibility of application of a borate-containing glass material while treating trophic wounds in children, suffering myelodysplasia.
 Маterials and methods. The data, concerning 3 children, who, while their newborn time were operated on for a spinal cord hernias, are presented. All the children have had myelodysplastic disordered trophic wound of the lower extremities, causing severe course of the wounds or the bedsores healing. Bioactive borate-containing glass «Mirragen», manufactured in USA, was proposed by medical centre «Меdyvo» for treatment of trophic wounds in children.
 Results. Application of bioactive borate-containing glass while treating trophic wounds in children, suffering myelodysplasia, was effective. Deep wounds during 8 weeks have had healed completely without complications, and a superficial wound—bedsore - during 5 weeks. The wounds have epithelized steadily, starting together from the bottom and periphery with velocity up to 12-15% of their square weekly. Negative general or local reaction towards a borate-containing glass in the patients was absent.
 Conclusion. Тemporary biomaterial, structured by a carcass, made of a borate-containing glass, guarantees a necessary form establishment, needed for creation of a new tissues and promotion of rapid healing of the wounds. Application of a bioactive borate-containing glass constitutes a safe and efficient method of treatment for trophic wounds in children, suffering myelodysplasia.

Highlights

  • Application of a borate–containing glass for the treatment of trophic wounds in children, suffering myelodysplasia

  • Оцінити можливість використання боратного скломатеріалу під час лікування трофічних ран у дітей з мієлодисплазією.

  • Усі діти через мієлодисплазію мали порушену трофіку нижніх кінцівок, що обумовило тяжкий перебіг загоювання ран або пролежнів.

Read more

Summary

Introduction

Application of a borate–containing glass for the treatment of trophic wounds in children, suffering myelodysplasia Оцінити можливість використання боратного скломатеріалу під час лікування трофічних ран у дітей з мієлодисплазією. Усі діти через мієлодисплазію мали порушену трофіку нижніх кінцівок, що обумовило тяжкий перебіг загоювання ран або пролежнів. Біоактивне боратне скло «Mirragen» виробництва США для лікування трофічних ран у цих дітей запропонував медичний центр «Медиво». Застосування біоактивного боратного скла під час лікування трофічних ран у дітей з мієлодисплазією було ефективне.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.